Skip to content
Fundology

SSE: 600276 · Health Technology

Which UK funds hold Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276)?

25 of the UK funds Fundology covers list Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A (600276) among their published holdings. The largest weight is 0.92% of HSBC MSCI China A UCITS ETF USD, as of 02/06/2025.

UK funds that hold Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

25 funds, largest weight first. A weight is the share of the fund’s money in this company.

UK funds holding Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, with the company’s weight in each fund and the date of the holdings
FundWeight in the fundHoldings as of
HSBC MSCI China A UCITS ETF USDIE00BF4NQ9040.92%
HSBC MSCI China UCITS ETF Accum USDIE0007P4PBU10.92%
HSBC MSCI AC Asia Pacific ex Japan Climate Paris Aligned UCITS ETF USDIE000XFORJ800.15%
iShares Healthcare Innovation UCITS ETFIE00BYZK47760.13%
HSBC MSCI China UCITS ETFIE00B44T3H880.10%
HSBC MSCI China A UCITS ETF AccumUSDIE000Z4OYPZ60.10%
Vanguard FTSE Emerging Markets UCITS ETFIE00B3VVMM840.04%
Vanguard ESG Emerging Markets All Cap Equity Index FundIE00BKV0VZ050.04%
Vanguard ESG Emerging Markets All Cap Equity Index FundIE00BKV0W0290.04%
Vanguard FTSE Emerging Markets UCITS ETF AccumUSDIE00BK5BR7330.04%
Vanguard ESG Emerging Markets All Cap UCITS ETF Accum USDIE000KPJJWM60.04%
Vanguard ESG Emerging Markets All Cap UCITS ETF USDIE0001VXZTV70.04%
State Street SPDR MSCI Emerging Markets UCITS ETF Acc USDIE00B469F8160.04%
State Street SPDR MSCI EM Asia UCITS ETF Accum USDIE00B466KX200.03%
HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USDIE00022VXYM70.03%
HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USDIE00BBQ2W3380.03%
Vanguard Emerging Markets Stock Index FundIE00B50MZ7240.02%
Vanguard Emerging Markets Stock Index FundIE00B51KVT960.02%
HSBC MSCI Emerging Markets UCITS ETFIE00B5SSQT160.02%
HSBC MSCI EMERGING MARKETS UCITS ETF AccumUSDIE000KCS7J590.02%
HSBC MSCI Emerging Markets Climate Paris Aligned UCITS ETFIE000FNVOB270.02%
Vanguard FTSE All-World UCITS ETFIE00B3RBWM250.01%
Vanguard FTSE All-World UCITS ETF Accum USDIE00BK5BQT800.01%
Vanguard FTSE All-World Ex-U.S. UCITS ETF Accum USDIE0009A5ADV90.01%
Vanguard FTSE All-World Ex-U.S. UCITS ETFIE000G1H7OC00.01%

Source: fund issuers’ published holdings, dates differ by fund

About Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A is listed on SSE under the symbol 600276, in the health technology sector as TradingView classifies it. Its market value was about $46.3bn (in US dollars) on 01/10/2026.

A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.

The list above comes from holdings the fund issuers publish, each dated. Some issuers publish every position; others publish only the largest ten, so a fund can hold Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A without being listed here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.

Share price

Latest price
47.20 CNY
+3.46%on the day
52-week range
41.89 CNY–71.66 CNY
Price change, 1 year
−31.6%
Price change, this year
−21.4%
Market value
$46.3bn
Price to earnings (12 months)
40.4

Source: TradingView, as of , at least 15 min delayed